Answers are grounded in this paper and cite their sources.
Commentary evaluates genetic contributions to patent ductus arteriosus, highlighting the role of ACTC1 variants in pediatrics, suggesting implications for future studies.
Patent ductus arteriosus (PDA) is a congenital cardiovascular condition characterized by the failure of the ductus arteriosus, a fetal vascular connection between the pulmonary artery and aorta, to close after birth. Physiologic closure of the ductus arteriosus is a tightly regulated process involving oxygen-mediated vasoconstriction, prostaglandin signaling, and subsequent vascular remodeling. Although environmental and perinatal factors, such as prematurity and respiratory distress syndrome, are well-recognized contributors, increasing evidence supports a role for genetic factors in modulating susceptibility to PDA. 1 The ACTC1 gene encodes α-cardiac actin, which is essential for cardiac contraction. Pathogenic variants of ACTC1 have been linked to a broad spectrum of cardiovascular phenotypes, including septal defects and cardiomyopathies. 2 However, the potential role of ACTC1 variants in the pathogenesis of PDA has yet to be elucidated. Zheng et al.’s article 3 entitled “Genetic variants of ACTC1 gene promoter in pediatric patients with sporadic patent ductus arteriosus and pathological significance” in the recent issue of Pediatric Research , represents an initial step toward addressing these gaps. In this commentary, we evaluate the strengths and limitations of this study and propose areas for future research.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: